OpenVSafe by OpenVAERS
Search V-safe

6G4-34619-18640

4 vaccinations 6 coded responses 34 check-ins 6 free-text entries 2 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
194 / PA
Registered
2021-10-09
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-09-10
    Dose 1 — Pfizer-BioNTech
  2. 2021-10-08
    Dose 2 — Pfizer-BioNTech
  3. 2021-10-09
    Registered in v-safe
  4. 2021-10-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-10-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2021-10-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Oral herpes, Vaccine positive rechallenge — Feeling: Good · Fatigue or tiredness
    Free text: Cold sore developed. This also happened with my first dose 2 days afterwards.
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-10-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-10-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Little to no appetite
    MedDRA releases: 2024-11 · check-in free text available
  9. 2021-10-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-10-15
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-10-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-10-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-11-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-11-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-11-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2022-01-07
    Survey response — 3 months, dose 2
    MedDRA: Breast tenderness, Dysmenorrhoea, Fatigue, Heavy menstrual bleeding, Menstrual clots, Menstrual disorder, Pelvic pain — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Menstrual issues (heavy/clotty periods, cramps that are outside of the time of a period, breast tenderness, general pelvic pain, fatigue)
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-01-07
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  18. 2022-01-10
  19. 2022-03-08
    Dose 3 — Pfizer-BioNTech
  20. 2022-03-08
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  21. 2022-03-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  22. 2022-03-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  23. 2022-03-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2022-03-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2022-03-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Muscle or body aches
    Adult check-in
  26. 2022-03-15
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  27. 2022-03-22
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-03-29
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-04-05
    Survey response — day 28, dose 3
    MedDRA: Condition aggravated, Pneumonitis, Pre-existing disease, Pulmonary function test decreased — Feeling: Good
    Free text: I have cystic fibrosis. My PFTs FEV1 is lower than normal despite treatment being the same. Experiencing more inflammation in my lungs.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-04-12
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-04-20
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-06-09
    Survey response — 3 months, dose 3
    MedDRA: Haemoptysis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Hemoptysis
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-09-07
    Dose 4 — Moderna
  34. 2022-09-07
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-09-27
    Survey response — day 14, dose 4
    MedDRA: Uterine leiomyoma — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Uterine Fibroids diagnosed 9/26/22
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-09-27
    Report sent to call center — day 14, dose 4
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  37. 2022-09-29
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-09-29
  39. 2022-09-29
  40. 2022-10-05
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-10-13
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  42. 2022-10-19
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  43. 2022-12-10
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  44. 2023-03-09
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-09-10Pfizer-BioNTech No
22021-10-08Pfizer-BioNTech No
32022-03-08Pfizer-BioNTech No
42022-09-07Moderna No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 2

2021-10-11

Systemic reaction (other): Cold sore developed. This also happened with my first dose 2 days afterwards.

2021-10-13

Systemic reaction (other): Little to no appetite

Release 10 — 3 months, dose 2

2022-01-07

Symptoms: Menstrual issues (heavy/clotty periods, cramps that are outside of the time of a period, breast tenderness, general pelvic pain, fatigue)

Release 11 — day 28, dose 3

2022-04-05

Symptoms: I have cystic fibrosis. My PFTs FEV1 is lower than normal despite treatment being the same. Experiencing more inflammation in my lungs.

Release 12 — 3 months, dose 3

2022-06-09

Symptoms: Hemoptysis

Release 12 — day 14, dose 4

2022-09-27

Symptoms: Uterine Fibroids diagnosed 9/26/22

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBreast tenderness · · ✓
SDCondition aggravated · · ✓
SDDysmenorrhoea · · ✓
SDFatigue · · ✓
SDHaemoptysis · · ✓
SDHeavy menstrual bleeding · · ✓
SDMenstrual clots · · ✓
SDMenstrual disorder · · ✓
SDPelvic pain · · ✓
SDPneumonitis · · ✓
SDPre-existing disease · · ✓
SDPulmonary function test decreased · · ✓
SDUterine leiomyoma · · ✓
SRODecreased appetite · · ✓
SROOral herpes · · ✓
SROReaction to previous exposure to any vaccine · · ○
SROVaccine positive rechallenge · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release